cdactin,nivolumab,cabozantinib
miyarisan,bms,osel
['cbm-588', 'congrat', 'rcc,(-irccs),(-srcc),(-urcc)']
fantastic presentation by on more intriguing data from io-based systemic therapy combinations +/- cbm-588 in mrcc! congratulations!! #onctwitter #asco23 
GU Medical Oncologist @ClevelandClinic | @GWSMHS Alum | Bladder, kidney, & prostate Ca; Tx-related toxicity biomarkers; career dev. | @ASCOTECAG | Views my own